mRNA-DC

N/A

Report date: 2026/05/06 20:02:28

First In Class

Base Information

Drug NamemRNA-DC

Drug Alias NamemRNA-DC

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulantsBaculoviral IAP repeat-containing protein 5 inhibitors

TargetsBaculoviral IAP repeat-containing protein 5

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesBeijing Tricision Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tricision Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A